CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: Kidney

CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: Kidney
复制标题

DOI:
10.1016/j.trim.2010.09.002
复制
发表时间:
2010-10-01
影响因子:
1.5
通讯作者:
Xiao, He
Xiao, He
中科院分区:
医学4区
文献类型:
--
作者:
Zhang, Ji-Lu;Sun, De-Jun;Xiao, He

文献摘要

被引文献

相似文献

在DBA/2->B6D2F1小鼠cGVHD模型中,Teff/Treg失衡导致狼疮性肾炎的发生和发展。在本文中,我们首次使用145-2C11抗体来治疗这些人类SLE样疾病动物。结果表明,短期小剂量抗CD3抗体治疗可显著缓解狼疮性肾病小鼠的蛋白尿、自身抗体产生、免疫复合物沉积和肾实质损害。值得注意的是,我们发现,与对照组相比,抗CD3抗体治疗的小鼠肾脏中Foxp3 mRNA的表达显著上调。同样,在抗CD3抗体处理的小鼠中,也观察到IL-10的肾脏mRNA丰度增加。相反,与炎症和纤维化相关的基因以及与效应性T细胞反应相关的细胞因子在抗CD3单抗治疗后下调。提示短期低剂量抗CD3抗体治疗可在慢性移植物抗宿主病的靶组织肾脏诱导分泌IL-10的Foxp3(+)调节性T细胞,抑制效应T细胞(Th1、Th2和Th17)的激活,从而减轻狼疮性肾炎的严重程度。(C)2010爱思唯尔B.V.保留所有权利。
Teff/Treg imbalance orchestrated the onset and the progression of the lupus nephritis in a DBA/2 -> B6D2F1 murine model with cGVHD. In this paper, we first used 145-2C11 Ab to treat these human SLE-like diseased animals. The results showed that short-term low-dose anti-CD3 antibody treatment induced a significant remission of established proteinuria, production of autoantibodies, immune complex deposition and renal parenchyma lesions in lupus nephritic mice. Of note, we found a robust up-regulation of Foxp3 mRNA expression in the target tissue: kidney from mice with anti-CD3 antibody treatment compared to those with control IgG treatment. Likewise, an increased renal mRNA abundance for IL-10 was also observed in anti-CD3 antibody treated mice. In contrast, genes associated with inflammation and fibrosis as well as cytokines related to effector T cell responses were down-regulated by anti-CD3 mAb treatment. These findings suggested that short-term low-dose anti-CD3 antibody treatment might induced an IL-10-secreting Foxp3(+) regulatory T cells in this cGVHD target tissue: kidney, that suppressed the activation of effector T cells (Th1, Th2 and Th17), thus ameliorating the severity of the lupus nephritis in mice. (C) 2010 Elsevier B.V. All rights reserved.